三迭纪
三迭纪提交中国首款3D打印药物T20j(阿哌沙班片)上市申请
三迭纪提交T20j（阿哌沙班片）上市申请，这是中国首款3D打印药物。申报紧随全国首张3D打印药品生产许可，并凸显与礼来、勃林格殷格翰、默克、BioNTech的全球合作。
三迭纪
三迭纪提交T20j（阿哌沙班片）上市申请，这是中国首款3D打印药物。申报紧随全国首张3D打印药品生产许可，并凸显与礼来、勃林格殷格翰、默克、BioNTech的全球合作。
Triastek
Triastek has submitted an NDA for T20j, China’s first 3D-printed drug, marking a regulatory milestone. The filing follows approval of the nation’s first 3D-printing drug manufacturing license and comes alongside Triastek’s broad 3D-printed pipeline and global pharma collaborations.